• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Robert F. Shaw, PharmD, MPH, BCPS, BCNSP

Latest:

Adding Glucose-Lowering Agents Delays Insulin Initiation and Prolongs Hyperglycemia

A review of national Veterans Health Administration data has identified how the number of glucose-lowering agents used prior to insulin initiation impacts glycemic control.





Loralee B. Rupp, MS

Latest:

Hepatitis B Virus Infection Testing and Prevalence Among Asian and Pacific Islanders

We examined the effect of country of origin on HBV testing and chronic HBV infection prevalence among APIs using data from Kaiser Permanente Hawaii.



Irina Miroshnik, MS

Latest:

Use of Well-Child Visits in High-Deductible Health Plans

When preventive care was exempt from the deductible, well-child visits did not change for children switching from traditional plans to high-deductible plans.



Annika Petersson, MSc, PhD

Latest:

Introduction of Cost Display Reduces Laboratory Test Utilization

Cost display and cost charge induce different test ordering behavior depending on the healthcare setting.


Raul Rosenthal, MD

Latest:

Cost-Effectiveness Analysis of Vagal Nerve Blocking for Morbid Obesity

This lifetime economic analysis demonstrates vagal nerve blocking therapy to be a cost-effective alternative to conventional therapy in class 2 and 3 obesity patients.




Part Two

Latest:

Immunotherapy in Cancer Care: Understanding the Impact of Shifting Treatment Paradigms in the Managed Care Setting

The previous issue of Evidence-Based Oncology (EBO) featured the first part of a condensed edition of a peer exchange on the future of immunotherapy in cancer care, which was convened by The American Journal of Managed Care. This edition of EBO features the rest of that exchange.











Gnanamba Varuni Kondagunta, MD

Latest:

Balancing Innovation With Cost in Diagnostic Testing

As clinical targets in more common malignancies emerge, testing and treatment options will increase. Balancing these choices with the high costs of new technology will be the challenge to ensure value in oncology care.



Gordon K. Norman, MD, MBA

Latest:

Diabetes Disease Management in Medicare Advantage Reduces Hospitalizations and Costs

A disease management program for Medicare Advantage patients with diabetes and coronary artery disease resulted in significantly reduced hospital admissions and total healthcare costs.


Jacquelyn S. Hunt, PharmD

Latest:

Oral Antidiabetic Medication Adherence and Glycemic Control in Managed Care

In this retrospective study of patients with diabetes, adherent patients were more likely to achieve glycemic control than nonadherent patients.




Emily R. Cox, PhD

Latest:

Lowering Copayments: Impact of Simvastatin Patent Expiration on Patient Adherence

Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.